Section Arrow
CGTX.NASDAQ
- Cognition Therapeutics
Quotes are at least 15-min delayed:2026/05/17 07:34 EDT
Regular Hours
Last
 1.14
-0.06 (-5.00%)
Day High 
1.2 
Prev. Close
1.2 
1-M High
1.36 
Volume 
765.65K 
Bid
1.14
Ask
1.17
Day Low
1.11 
Open
1.2 
1-M Low
0.98 
Market Cap 
107.40M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 1.22 
20-SMA 1.22 
50-SMA 1.08 
52-W High 3.83 
52-W Low 0.222301 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.23/-0.19
Enterprise Value
107.59M
Balance Sheet
Book Value Per Share
0.33
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
HCWBHCW Biologics Inc1.22+0.883+262.02%-- 
ADTXAditxt Inc.0.0632-0.0036-5.39%-- 
RXRXRecursion Pharmaceuticals2.93-0.11-3.62%-- 
GERNGeron Corp1.29-0.11-7.86%-- 
NTLAIntellia Therapeutics13.67+0.58+4.43%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system (CNS) and retina. It aims to develop disease-modifying therapies for patients with these disorders. Its product candidate, zervimesine (CT1812), is an orally delivered small molecule designed to protect neuronal synapses by preventing the bindingof oligomers of pathogenic proteins, including beta-amyloid and alpha-synuclein. These protein oligomers have been linked to the progression of degenerative diseases such as Alzheimer's disease (AD) and dementia with Lewy bodies (DLB).
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.